Study #2022-1071
Blood collection to evaluate biomarkers in individuals with suspicion of cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Blood collection to evaluate biomarkers in individuals with suspicion of cancer
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Breast;Colon;Esophagus;Hodgkin Lymphoma;Ill-Defined Sites;Larynx;Liver;Lung;Lymphoid Leukemia;Melanoma, Skin;Multiple Myeloma;Non-Hodgkin's Lymphoma;Other Digestive Organ;Other Endocrine System;Other Female Genital;Other Respiratory and Intrathoracic Organs;Other Urinary;Ovary;Pancreas;Prostate;Rectum;Small Intestine;Soft Tissue;Stomach;Thyroid;Unknown Sites
Study phase:
Not applicable
Physician name:
Edwin Ostrin
Department:
General Internal Medicine
For general questions about clinical trials:
1-844-252-9709
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.